NUVL
USDNuvalent Inc. Class A Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$94.250
High
$95.225
Low
$92.075
Volume
0.28M
Company Fundamentals
Market Cap
6.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.46M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Nuvalent to Present Patient-Reported Outcomes Data from ARROS-1 Trial of ROS1-Selective Inhibitor, Zidesamtinib, at 2025 IASLC ASCO North America Conference on Lung Cancer
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
UBS Maintains Buy on Nuvalent, Raises Price Target to $132
UBS analyst David Dai maintains Nuvalent with a Buy and raises the price target from $114 to $132.
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports Third Quarter 2025 Financial Results
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...
Piper Sandler Maintains Overweight on Nuvalent, Raises Price Target to $128
Piper Sandler analyst Kelsey Goodwin maintains Nuvalent with a Overweight and raises the price target from $112 to $128.
Related Stocks
BIIB
Biogen
INBX
Inhibrx Biosciences Inc.
EVG
Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund Common Shares of Beneficial Interest
JOUT
Johnson Outdoors Inc.
SLGN
Silgan Holdings Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.